Showing results (311-320 of 327) with videos related to
Sort By:
Pageof 33
Neurology|March 10, 2012
Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune StudyA-L Ponsonby, R M Lucas, I A van der Mei, et al.International Journal of Cancer|July 3, 1996
Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARCP Boyle, P Maisonneuve, B Bueno de Mesquita, et al.Nature|March 10, 2001
Skewed maturation of memory HIV-specific CD8 T lymphocytesP Champagne, G S Ogg, A S King, et al.American Journal of Epidemiology|April 16, 2013
Occupational exposure and risk of central nervous system demyelinationP C Valery, R M Lucas, D B Williams, et al.Journal of Virology|December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapyG S Ogg, X Jin, S Bonhoeffer, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimenT M Allen, T U Vogel, D H Fuller, et al.Clinical and Experimental Immunology|April 23, 2013
Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentiallyA-M Hughes, R M Lucas, A J McMichael, et al.Science (New York, N.Y.)|April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNAG S Ogg, X Jin, S Bonhoeffer, et al.Journal of the National Cancer Institute|August 6, 1997
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on CancerW A Zatonski, A B Lowenfels, P Boyle, et al.Immunity|May 24, 2001
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complexX N Xu, M A Purbhoo, N Chen, et al.Pageof 33